AstraZeneca CEO doubles down on U.S. amid rumors of listing shift

Thread starter International: Top News And Analysis
Start date Jul 29, 2025

International: Top News And Analysis

Guest

Jul 29, 2025

AstraZeneca CEO Pascal Soriot said the U.K.-listed company had many reasons to be in the U.S., adding that it was "rapidly transferring manufacturing" across the Atlantic.

Continue reading...

You must log in or register to reply here.

Facebook X Bluesky LinkedIn Reddit Pinterest Tumblr WhatsApp Email Link

Thread Information

Title: AstraZeneca CEO doubles down on U.S. amid rumors of listing shift

Prefix: N/A

Forum: World News

Start date: Jul 29, 2025

Last reply date: Jul 29, 2025

Replies: 0

Thread Tags

Thread statistics

Created: International: Top News And Analysis, Jul 29, 2025

Replies: 0

Views: 9

About Us

XenTR Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.

It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout.

Color picker

Search